首页
>>
产品中心
>>
蛋白产品
>>
重组蛋白
>
Recombinant Human CD266/TNFRSF12A Protein, C-hFc and His tag

Recombinant Human CD266/TNFRSF12A Protein, C-hFc and His tag

产品编号

KMH415

别名

肿瘤坏死因子受体超家族成员12A, FN14, CD266, TWEAKR, TNF receptor superfamily member 12A

规格
  • 20ug
  • 50ug
  • 100ug
  • 200ug
  • 1mg
产品介绍
Catalog NumberKMH415
Alias肿瘤坏死因子受体超家族成员12A, FN14, CD266, TWEAKR, TNF receptor superfamily member 12A
Size20ug, 50ug, 100ug, 200ug, 1mg
Product DescriptionKMH415 Recombinant Human CD266/TNFRSF12A Protein, C-hFc and His tag contains the human TNFRSF12A(Glu28-Trp79) was expressed in Mammalian cells.
Molecular NameTNFRSF12A
Product IntroductionTNFRSF12A在免疫应答中起到重要的调节作用,调节细胞生长与分化。
Molecular Weight35-45 kDa
Expression SystemHEK293F Cells
SpeciesHuman
Concentration联系销售经理获得最新批次的浓度
Purity≥92%
SDS-PAGE
PurificationAffinity Purification
Uniprot IDQ9NP84
Storage ConditionStore the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles.
FormulationPBS
Shipping ConditionThis product is shipped on ice packs or dry ice.
BackgroundTNFSF12 is a cytokine that is part of the TNF ligand family. TNFSF12 is a ligand for the FN14/TWEAKR receptor. TNFSF12 has overlapping signaling functions with TNF, but displays a much wider tissue distribution. TNFSF12 induces apoptosis through multiple pathways of cell death in a cell type-specific manner. TNFSF12 promotes proliferation and migration of endothelial cells, and therefore acts as a regulator of angiogenesis. TNFSF12 is expressed in adult heart, pancreas, skeletal muscle, small intestine, spleen and peripheral blood lymphocytes. TWEAK h induces NFkB and chemokine secretion. TNFSF12 exerts an apoptotic activity in HT-29 human adenocarcinoma cells whilst cultured in the presence of IFN. TNFSF12 promotes proliferation and migration of endothelial cells.
Endotoxin< 0.1 EU per ug
Protein FamilyCD molecule
Biological ActivityMeasured by its ability to inhibit TWEAK-induced apoptosis in HT-29 human colon adenocarcinoma cells. The ED50 for this effect is 2-10 ug/mL in the presence of human TWEAK.
Product Declaration该产品仅供科研使用,不可直接用于人体或注射。
FAQ
  • 如何判断蛋白是否有抗体反应性?

    可以使用ELISA、Western blot或免疫沉淀等技术来检测蛋白与特定抗体的结合反应性。

  • 如何避免蛋白在纯化过程中的损失?

    使用温和的纯化条件、优化缓冲液成分和减少操作步骤,可以有效减少蛋白的损失。

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价